Genes linked to the development of AMD, but not to its treatment

The four gene variants linked to the development of AMD do not influence how patients respond to treatment using Lucentis and Avastin.

 

The gene variants CFH, ARMS2, HTRA1 and C3 encourage the onset of AMD. Researchers wanted to find out whether they also affected patient response to drugs used to treat the “wet” form of the disease. This would have allowed them to tailor treatment based on a patient’s genetic profile.

 

The researchers also studied the genotypes of 73% of the 1,149 participants in the Comparison of AMD Treatment Trials (CATT). Then the patients’ gene types were compared to their responses to treatment. Unfortunately, they did not find an association among the genes and the treatment responses. These results confirm those from a study conducted in 2012 by the American Academy of Ophthalmology.

 

“Our genetic research team remains hopeful that gene variants that predict patient response to AMD treatments will be identified soon,” said Dr. Stephanie Hagstrom, lead researcher in the CATT study. This would enable a significant advance in ophthalmologists’ ability to individualize treatment. 

 

Source: http://www.aao.org/newsroom/release/20130213.cfm

Featured Posts

Anatomy of Eyewear: The Earth’s Bounty, an Exploration of Sustainable Eyewear

The majority of frames available in your average dispensary will be made from one of two materials, metal or a form of plastic. Eyewear is not limited to only these choices!  

Learn More

Jennifer Jones Joins FBC as New President And CEO

Fighting Blindness Canada (FBC) announces the appointment of Jennifer Jones as the new President and Chief Executive Officer (CEO), effective May 23, 2023.

Read more

Bash, the Shinning Elegance

Devoted to offering products that enhance the feeling of well-being, Ba&sh offers a sunwear collection which indulges femininity and elegance.

Read more

IRIS, The Visual Group, and DIAGNOS Launch IRIS-ai

IRIS-ai, an artificial intelligence-powered tool for ocular disease screening, has officially been implemented in 20 stores across Quebec.

Read more

Cyclists Ride Through the GTA to Bring Hope to Canadians Living with Blindness

On Saturday, June 3rd, hundreds of cyclists will be gearing up and riding together in Alliston, ON for Fighting Blindness Canada’s 15th Annual Cycle for Sight fundraising event.

Read more

Anatomy of Eyewear: The Earth’s Bounty, an Exploration of Sustainable Eyewear

The majority of frames available in your average dispensary will be made from one of two materials, metal or a form of plastic. Eyewear is not limited to only these choices!  

Learn More

Jennifer Jones Joins FBC as New President And CEO

Fighting Blindness Canada (FBC) announces the appointment of Jennifer Jones as the new President and Chief Executive Officer (CEO), effective May 23, 2023.

Read More

Bash, the Shinning Elegance

Devoted to offering products that enhance the feeling of well-being, Ba&sh offers a sunwear collection which indulges femininity and elegance.

Read More

IRIS, The Visual Group, and DIAGNOS Launch IRIS-ai

IRIS-ai, an artificial intelligence-powered tool for ocular disease screening, has officially been implemented in 20 stores across Quebec.

Read More

Cyclists Ride Through the GTA to Bring Hope to Canadians Living with Blindness

On Saturday, June 3rd, hundreds of cyclists will be gearing up and riding together in Alliston, ON for Fighting Blindness Canada’s 15th Annual Cycle for Sight fundraising event.

Read More

Anatomy of Eyewear: The Earth’s Bounty, an Exploration of Sustainable Eyewear

The majority of frames available in your average dispensary will be made from one of two materials, metal or a form of plastic. Eyewear is not limited to only these choices!  

Learn More

Jennifer Jones Joins FBC as New President And CEO

Fighting Blindness Canada (FBC) announces the appointment of Jennifer Jones as the new President and Chief Executive Officer (CEO), effective May 23, 2023.

Read more

Bash, the Shinning Elegance

Devoted to offering products that enhance the feeling of well-being, Ba&sh offers a sunwear collection which indulges femininity and elegance.

Read more

IRIS, The Visual Group, and DIAGNOS Launch IRIS-ai

IRIS-ai, an artificial intelligence-powered tool for ocular disease screening, has officially been implemented in 20 stores across Quebec.

Read more

Cyclists Ride Through the GTA to Bring Hope to Canadians Living with Blindness

On Saturday, June 3rd, hundreds of cyclists will be gearing up and riding together in Alliston, ON for Fighting Blindness Canada’s 15th Annual Cycle for Sight fundraising event.

Read more

Anatomy of Eyewear: The Earth’s Bounty, an Exploration of Sustainable Eyewear

The majority of frames available in your average dispensary will be made from one of two materials, metal or a form of plastic. Eyewear is not limited to only these choices!  

Learn More

Jennifer Jones Joins FBC as New President And CEO

Fighting Blindness Canada (FBC) announces the appointment of Jennifer Jones as the new President and Chief Executive Officer (CEO), effective May 23, 2023.

Read more

Bash, the Shinning Elegance

Devoted to offering products that enhance the feeling of well-being, Ba&sh offers a sunwear collection which indulges femininity and elegance.

Read more

IRIS, The Visual Group, and DIAGNOS Launch IRIS-ai

IRIS-ai, an artificial intelligence-powered tool for ocular disease screening, has officially been implemented in 20 stores across Quebec.

Read more

Cyclists Ride Through the GTA to Bring Hope to Canadians Living with Blindness

On Saturday, June 3rd, hundreds of cyclists will be gearing up and riding together in Alliston, ON for Fighting Blindness Canada’s 15th Annual Cycle for Sight fundraising event.

Read more